I have feeling there will likely be an opportunistic T/O if we get anoth CRL from GDA, the bidder(s) full knowing we will get approval in 2025 and advancing other product to BLA ... The "opportunist" can be GG (as he can then afford at that price - maybe with some loan), or a big pharma ...
I hink that is why GG is edging the 20% ....
And who knows, if SI and GG are working together, and GG is planning a T/O at a low ball price if we get a CRL, then that may explain why no CR now ... (?)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.52 |
Change
-0.060(2.33%) |
Mkt cap ! $3.225B | |||
| Open | High | Low | Value | Volume |
| $2.58 | $2.61 | $2.50 | $12.63M | 4.955M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8366 | $2.51 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.53 | 8780 | 4 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| MSB (ASX) Chart |